Shor, Dana
Louie, Alexander V.
Zeng, Kang Liang
Menjak, Ines B.
Atenafu, Eshetu G.
Chia-Lin Tseng,
Detsky, Jay
Larouche, Jeremie
Zhang, Beibei
Soliman, Hany
Myrehaug, Sten
Maralani, Pejman
Hwang, David M.
Sahgal, Arjun
Chen, Hanbo
Article History
Received: 6 January 2024
Accepted: 7 February 2024
First Online: 25 March 2024
Declarations
:
: The authors declare no competing interests.
: Dana Shor: None.Alexander V. Louie: received honoraria from AstraZeneca for speakers bureau and advisory board participation unrelated to this work.K. Liang Zeng: None.Ines Menjak: received honoraria from AstraZeneca and Merck for presentations this year, education funding from AstraZeneca.Eshetu G. Atenafu: None.Chia-Lin Tseng: has received travel accommodations/expenses and honoraria for past educational seminars from Elekta and Abbvie, belongs to the Elekta MR-Linac Research Consortium and Lead for the Brain Tumor Site Group, and is an advisor/consultant with Sanofi.Jay Detsky: None.Jeremie Larouche: None.Beibei Zhang: None.Hany Soliman: None.Sten Myrehaug: None.Pejman Jabehdar Maralani: None.David M. Hwang: received research grants with AstraZeneca, Pfizer, EMD-Serono; has consulted for Novartis, Merck, Amgen, Bayer, Bristol-Myers-Squibb, AstraZeneca, Roche, Eli Lilly, GlaxoSmithKline (GSK); has received honoraria for past educational seminars from Merck, Novartis, AstraZeneca, Pfizer.Arjun Sahgal: received research grants with Elekta AB, Varian, Seagen Inc, BrainLAB; has consulted for Elekta, and BrainLAB; has received honoraria for past educational seminars from AstraZeneca, Elekta, Varian, BrainLAB, Seagen Inc.; is a Vice President of the International Stereotactic Radiosurgery Society (ISRS); is the past co-chair of the AO Spine Knowledge Forum Tumor; belongs to the Elekta MR-Linac Research Consortium.Hanbo Chen: None.